These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2576434)

  • 21. Influences on the density of beta-adrenergic receptors in the cornea and iris--ciliary body of the rabbit.
    Neufeld AH; Zawistowski KA; Page ED; Bromberg BB
    Invest Ophthalmol Vis Sci; 1978 Nov; 17(11):1069-75. PubMed ID: 212382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition of beta adrenergic receptors in human and rabbit ciliary process and heart.
    Nathanson JA
    J Pharmacol Exp Ther; 1985 Jan; 232(1):119-26. PubMed ID: 2856938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timolol inhibits adenylate cyclase activity in the iris-ciliary body and trabecular meshwork of the eye and blocks activation of the enzyme by salbutamol.
    Phylactos AC
    Acta Ophthalmol (Copenh); 1986 Dec; 64(6):613-22. PubMed ID: 3028033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 and F2 alpha binding sites in the bovine iris ciliary body.
    Csukas S; Bhattacherjee P; Rhodes L; Paterson CA
    Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2237-45. PubMed ID: 8389343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R-enantiomer of timolol: a potential selective ocular antihypertensive agent.
    Share NN; Lotti VJ; Gautheron P; Schmitt C; Gross DM; Hall RA; Stone CA
    Graefes Arch Clin Exp Ophthalmol; 1984; 221(5):234-8. PubMed ID: 6092239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application site dependent ocular absorption of timolol.
    Urtti A; Sendo T; Pipkin JD; Rork G; Repta AJ
    J Ocul Pharmacol; 1988; 4(4):335-43. PubMed ID: 3246568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of timolol on the active transport across the ciliary epithelium.
    Nagasubramanian S; Poinoosawmy D
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 6)():665-6. PubMed ID: 3477895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of metabolism of timolol by ocular tissues.
    Putterman GJ; Davidson J; Albert J
    J Ocul Pharmacol; 1985; 1(3):287-96. PubMed ID: 3880080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro determination of the ability of drugs to bind to adrenergic receptors.
    Neufeld AH; Page ED
    Invest Ophthalmol Vis Sci; 1977 Dec; 16(12):1118-24. PubMed ID: 200584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit iris-ciliary body.
    Jumblatt JE; Liu JG; North GT
    Curr Eye Res; 1987 Jun; 6(6):767-77. PubMed ID: 3038473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increase in beta-adrenergic receptors in rabbits in long-term local administration of beta-blockers].
    Kahle G; Kaulen P; Scherer V; Wollensak J
    Ophthalmologe; 1993 Dec; 90(6):626-30. PubMed ID: 7907242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular pharmacokinetic/pharmacodynamic modeling for timolol in rabbits using a telemetry system.
    Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
    Biol Pharm Bull; 2008 May; 31(5):970-5. PubMed ID: 18451528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Active transport of a beta-blocker in the anterior uvea of albino rabbits].
    Matsumoto S; Araie M; Takase M
    Nippon Ganka Gakkai Zasshi; 1986 Jul; 90(7):991-7. PubMed ID: 2876604
    [No Abstract]   [Full Text] [Related]  

  • 35. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body.
    Wax MB; Molinoff PB
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):420-30. PubMed ID: 3030954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye.
    Kaplan-Messas A; Naveh N; Avni I; Marshall J
    Eur J Ophthalmol; 2003; 13(1):18-23. PubMed ID: 12635670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular timolol levels after drug withdrawal: an experimental model.
    Trope GE; Menon IA; Liu GS; Thibodeau JR; Becker MA; Persad SD
    Can J Ophthalmol; 1994 Oct; 29(5):217-9. PubMed ID: 7859172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study on distribution of different hydroxyproline fractions in the bovine ocular tissues.
    Siddiqi NJ; Sharma B; Alhomida AS
    Mol Cell Biochem; 2001 Jan; 217(1-2):67-71. PubMed ID: 11269667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of antiglaucomatous drugs to synthetic melanin and their hypotensive effects on pigmented and nonpigmented rabbit eyes.
    Nagata A; Mishima HK; Kiuchi Y; Hirota A; Kurokawa T; Ishibashi S
    Jpn J Ophthalmol; 1993; 37(1):32-8. PubMed ID: 8100592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin.
    Mittag TW; Tormay A; Messenger M; Podos SM
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):163-9. PubMed ID: 2857689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.